Prime Medicine, Inc.PRMENASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank83
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-2.57
↑ 98% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-149.34
Historical baseline
PeriodValueYoY Change
2025-2.57-45.2%
2024-1.77+56.5%
2023-4.07+72.6%
2022-14.83-66.6%
2021-8.90+97.9%
2020-431.49+25.8%
2019-581.80-